Literature DB >> 18676543

Pediatric autoimmune neuropsychiatric disorders associated with streptococcus: comparison of diagnosis and treatment in the community and at a specialty clinic.

Vilma Gabbay1, Barbara J Coffey, James S Babb, Laura Meyer, Carly Wachtel, Seeba Anam, Beth Rabinovitz.   

Abstract

OBJECTIVES: This study aimed to examine whether pediatric autoimmune neuropsychiatric disorders associated with streptococcus were appropriately diagnosed in the community and to determine subsequent rates of unwarranted use of antibiotic treatment for tics and obsessive-compulsive symptoms without the identification of an infection.
METHODS: The design was a retrospective, cross-sectional, observational study of 176 children and adolescents who were evaluated in a specialty program for tics, Tourette's disorder, and related problems. Previously published diagnostic criteria were used to establish the diagnosis of pediatric autoimmune neuropsychiatric disorders associated with streptococcus in our clinic.
RESULTS: Subjects were significantly less likely to receive a diagnosis of pediatric autoimmune neuropsychiatric disorders associated with streptococcus at the specialty clinic than in the community. In the community, subjects were significantly more likely to be treated with antibiotics or immunosuppressant medication if they received a diagnosis of pediatric autoimmune neuropsychiatric disorders associated with streptococcus. Of the 27 subjects with a community diagnosis of pediatric autoimmune neuropsychiatric disorders associated with streptococcus who were treated with antibiotics, 22 (82%) were treated without laboratory evidence of an infection; 2 were treated with immunomodulatory medications.
CONCLUSIONS: Our results support our hypothesis that pediatric autoimmune neuropsychiatric disorders associated with streptococcus are frequently diagnosed in the community without the application of all working diagnostic criteria. This phenomenon has resulted in unwarranted use of antibiotic treatment for tics/obsessive-compulsive disorder without evidence of laboratory infection.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18676543      PMCID: PMC2770722          DOI: 10.1542/peds.2007-1307

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  33 in total

1.  Managing antibiotic resistance.

Authors:  R P Wenzel; M B Edmond
Journal:  N Engl J Med       Date:  2000-12-28       Impact factor: 91.245

2.  An animal model of Tourette's syndrome.

Authors:  Jane R Taylor; Syed A Morshed; Salina Parveen; Marcos T Mercadante; Lawrence Scahill; Bradley S Peterson; Robert A King; James F Leckman; Paul J Lombroso
Journal:  Am J Psychiatry       Date:  2002-04       Impact factor: 18.112

3.  Tourette's syndrome: a cross sectional study to examine the PANDAS hypothesis.

Authors:  A J Church; R C Dale; A J Lees; G Giovannoni; M M Robertson
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-05       Impact factor: 10.154

4.  Progress toward analysis of D8/17 binding to B cells in children with obsessive compulsive disorder and/or chronic tic disorder.

Authors:  T K Murphy; N Benson; A Zaytoun; M Yang; R Braylan; E Ayoub; W K Goodman
Journal:  J Neuroimmunol       Date:  2001-11-01       Impact factor: 3.478

5.  Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States.

Authors:  C G Whitney; M M Farley; J Hadler; L H Harrison; C Lexau; A Reingold; L Lefkowitz; P R Cieslak; M Cetron; E R Zell; J H Jorgensen; A Schuchat
Journal:  N Engl J Med       Date:  2000-12-28       Impact factor: 91.245

6.  Informativeness of structured diagnostic interviews in the identification of Tourette's disorder in referred youth.

Authors:  B J Coffey; J Biederman; T Spencer; D A Geller; S V Faraone; C A Bellordre
Journal:  J Nerv Ment Dis       Date:  2000-09       Impact factor: 2.254

7.  Prospective identification and treatment of children with pediatric autoimmune neuropsychiatric disorder associated with group A streptococcal infection (PANDAS).

Authors:  Marie Lynd Murphy; Michael E Pichichero
Journal:  Arch Pediatr Adolesc Med       Date:  2002-04

8.  Detecting pediatric autoimmune neuropsychiatric disorders associated with streptococcus in children with obsessive-compulsive disorder and tics.

Authors:  Tanya K Murphy; Muhammad Sajid; Ohel Soto; Nathan Shapira; Paula Edge; Mark Yang; Mark H Lewis; Wayne K Goodman
Journal:  Biol Psychiatry       Date:  2004-01-01       Impact factor: 13.382

9.  Trends in antimicrobial prescribing rates for children and adolescents.

Authors:  Linda F McCaig; Richard E Besser; James M Hughes
Journal:  JAMA       Date:  2002-06-19       Impact factor: 56.272

10.  Anti-brain antibodies in PANDAS versus uncomplicated streptococcal infection.

Authors:  Piero Pavone; Rio Bianchini; Enrico Parano; Gemma Incorpora; Renata Rizzo; Luigi Mazzone; Rosario R Trifiletti
Journal:  Pediatr Neurol       Date:  2004-02       Impact factor: 3.372

View more
  16 in total

Review 1.  Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections: an overview.

Authors:  S Esposito; S Bianchini; E Baggi; M Fattizzo; D Rigante
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-06-24       Impact factor: 3.267

Review 2.  Obsessive-compulsive disorder: a review of the diagnostic criteria and possible subtypes and dimensional specifiers for DSM-V.

Authors:  James F Leckman; Damiaan Denys; H Blair Simpson; David Mataix-Cols; Eric Hollander; Sanjaya Saxena; Euripedes C Miguel; Scott L Rauch; Wayne K Goodman; Katharine A Phillips; Dan J Stein
Journal:  Depress Anxiety       Date:  2010-06       Impact factor: 6.505

3.  Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections.

Authors:  Jason Tan; Christine H Smith; Ran D Goldman
Journal:  Can Fam Physician       Date:  2012-09       Impact factor: 3.275

4.  Five youth with pediatric acute-onset neuropsychiatric syndrome of differing etiologies.

Authors:  Jennifer Frankovich; Margo Thienemann; Sonal Rana; Kiki Chang
Journal:  J Child Adolesc Psychopharmacol       Date:  2015-02       Impact factor: 2.576

5.  Clinical presentation of pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections in research and community settings.

Authors:  Susan E Swedo; Jakob Seidlitz; Miro Kovacevic; M Elizabeth Latimer; Rebecca Hommer; Lorraine Lougee; Paul Grant
Journal:  J Child Adolesc Psychopharmacol       Date:  2015-02       Impact factor: 2.576

6.  PANDAS/PANS in childhood: Controversies and evidence.

Authors:  Colin Wilbur; Ari Bitnun; Sefi Kronenberg; Ronald M Laxer; Deborah M Levy; William J Logan; Michelle Shouldice; E Ann Yeh
Journal:  Paediatr Child Health       Date:  2018-12-09       Impact factor: 2.253

Review 7.  The immunobiology of Tourette's disorder, pediatric autoimmune neuropsychiatric disorders associated with Streptococcus, and related disorders: a way forward.

Authors:  Tanya K Murphy; Roger Kurlan; James Leckman
Journal:  J Child Adolesc Psychopharmacol       Date:  2010-08       Impact factor: 2.576

8.  Streptococcal upper respiratory tract infections and exacerbations of tic and obsessive-compulsive symptoms: a prospective longitudinal study.

Authors:  James F Leckman; Robert A King; Donald L Gilbert; Barbara J Coffey; Harvey S Singer; Leon S Dure; Heidi Grantz; Liliya Katsovich; Haiqun Lin; Paul J Lombroso; Ivana Kawikova; Dwight R Johnson; Roger M Kurlan; Edward L Kaplan
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2010-12-31       Impact factor: 8.829

9.  Clinical evaluation of youth with pediatric acute-onset neuropsychiatric syndrome (PANS): recommendations from the 2013 PANS Consensus Conference.

Authors:  Kiki Chang; Jennifer Frankovich; Michael Cooperstock; Madeleine W Cunningham; M Elizabeth Latimer; Tanya K Murphy; Mark Pasternack; Margo Thienemann; Kyle Williams; Jolan Walter; Susan E Swedo
Journal:  J Child Adolesc Psychopharmacol       Date:  2014-10-17       Impact factor: 2.576

10.  Psychotherapy and medication management strategies for obsessive-compulsive disorder.

Authors:  Kelda H Walsh; Christopher J McDougle
Journal:  Neuropsychiatr Dis Treat       Date:  2011-08-23       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.